A microassay for guanosine 3′,5′-monophosphate phosphodiesterase activity
✍ Scribed by Richard Fertel; Benjamin Weiss
- Publisher
- Elsevier Science
- Year
- 1974
- Tongue
- English
- Weight
- 835 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A possible defect of guanosine 3Ј-5Ј-cyclic monophosphate (cGMP) content in the renal tissue caused by an increased activity of cGMP phosphodiesterase (PDE) has, so far, not been evaluated in the pathogenesis of renal resistance to endogenous natriuretic peptides (ENP) in cirrhosis with ascites. To
A column chromatogrnphic sy;itrm has been developed for isolation and purification of cAMP and cGMP simultnneously from small tissue samples. In this system, a column of neutral aluminum oxide equilibrated in Tris-HCl buffer, pH 7.5 was used to purify cyclic nucleotides from olhe~ nucleotides in non
A novel nonradioactive, microassay method has been developed to determine simultaneously the two enzymatic activities of orotate phosphoribosyltransferase (OPRTase) and orotidine 5'-monophosphate decarboxylase (ODCase), either as a bifunctional protein (uridine 5'-monophosphate synthase, UMPS) or as
We developed a sensitive and nonradioactive fluorometric assay for cyclic guanosine 3,5-monophosphate (cGMP). Guanine nucleotides except cGMP were enzymatically phosphorylated to GTP. cGMP, absorbed into a Sep-Pak amino propyl cartridge, was eluted separately from GTP. Purified cGMP was enzymaticall